Injectable hydrogel relieves osteoarthritis pain and repairs cartilage in preclinical tests

For millions of people living with osteoarthritis, daily life can involve a frustrating cycle of pain and stiffness. While current treatments like over-the-counter medications or steroid injections can temporarily dull the ache, they do not stop the joint from deteriorating. A Yale study published in the journal Bioactive Materials found that the medication lacosamide acts as a highly effective, dual-purpose treatment that relieves joint pain and reverses cartilage damage in osteoarthritis, especially when a specialized hydrogel delivers the drug directly into the joint.

Sign the Petition

Urge Virbac to Begin FDA Approval for Interferon Omega - Help cats with FIV, FeLV & More

The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk – The USA Potato

TCL #18: Climeworks' Carbon Capture Boost, Siemens' Green Hydrogen Push, Pfizer's FDA Win, Avantium's Bio-Based Packaging & More

In this edition of The Chem Ledger, I cover Climeworks’ latest advancement in Direct Air Capture through its collaboration with Avantium, Siemens’ strategic partnership to expand green hydrogen production, and Pfizer’s FDA approval for its antibody-drug conjugate Adcetris. Plus, Avantium and Amcor’s push for sustainable, plant-based packaging, Owens

Apple AirPods Pro granted FDA approval to serve as hearing aids | TechCrunch

The FDA on Thursday announced that it has granted what it calls “the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature.”